Thu, Nov 28, 2024
Dr. Reddy's Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal carcinoma (NPC) -- a rare and aggressive form of head and neck cancer that originates in the nasopharynx, the upper part of the throat.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
